Loading
Latest filing published 25 Feb 2021 for SOL Global Investments Corp. (formerly Scythian Biosciences Corp.), €6,271.
No signal scores available.
Olivier Marc Centner discloses dealings in SOL Global Investments Corp. (formerly Scythian Biosciences Corp.) to SEDI. In total, 3 filings cover trades dated 24 February 2021.
No open-market sale appears; the market trades are 3 purchases worth €25k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €6,271 and half below.
The newest entry dates from 25 February 2021: an open-market purchase of €6,271, in SOL Global Investments Corp. (formerly Scythian Biosciences Corp.). Between a trade and the moment it shows up on SEDI, the median delay is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations